Insider Buying Signals: 3 Healthcare Stocks to Watch
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
Insider buying and share buybacks have put Prothena, Rapport Therapeutics and Azenta on the radar. See the catalysts and risks behind each stock.
Directly affected
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story.
- LLY Eli Lilly and+23.6% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
- JNJ Johnson & Johnson+8.5% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
- PFE Pfizer+4.4% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
- MRK Merck+4.3% 30d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| RAPP | -0.17% | -5.84% | base | +2.00% | after close | after close | after close |
| AZTA | -3.37% | -3.33% | base | +17.94% | after close | after close | after close |
| XLV | +0.42% | -2.16% | base | -0.91% | after close | after close | after close |
| XBI | +2.62% | -1.83% | base | +0.25% | after close | after close | after close |
| LLY | -1.00% | -5.42% | base | -1.01% | after close | after close | after close |
| JNJ | -1.58% | -1.58% | base | -1.24% | after close | after close | after close |
| PFE | +4.87% | +0.09% | base | -0.54% | after close | after close | after close |
| MRK | +1.60% | -0.83% | base | -1.52% | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Insider Buying Signals: 3 Healthcare Stocks to Watch InvestorPlace
Source: InvestorPlace
Price since this story was published: Select Sector Spdr Tr (XLV)
| Company | When | Move | Status |
|---|---|---|---|
| AZTA | that day | +17.94% | still updating |
| AZTA | three days earlier | -3.33% | final price |
| AZTA | five days earlier | -3.37% | final price |
| Johnson & Johnson (JNJ) | that day | -1.24% | still updating |
| Johnson & Johnson (JNJ) | three days earlier | -1.58% | final price |
| Johnson & Johnson (JNJ) | five days earlier | -1.58% | final price |
| Eli Lilly (LLY) | that day | -1.01% | still updating |
| Eli Lilly (LLY) | three days earlier | -5.42% | final price |
| Eli Lilly (LLY) | five days earlier | -1.00% | final price |
| Merck (MRK) | that day | -1.52% | still updating |
| Merck (MRK) | three days earlier | -0.83% | final price |
| Merck (MRK) | five days earlier | +1.60% | final price |
| Pfizer (PFE) | that day | -0.54% | still updating |
| Pfizer (PFE) | three days earlier | +0.09% | final price |
| Pfizer (PFE) | five days earlier | +4.87% | final price |
| RAPP | that day | +2.00% | still updating |
| RAPP | three days earlier | -5.84% | final price |
| RAPP | five days earlier | -0.17% | final price |
| Spdr Series Trust (XBI) | that day | +0.25% | still updating |
| Spdr Series Trust (XBI) | three days earlier | -1.83% | final price |
| Spdr Series Trust (XBI) | five days earlier | +2.62% | final price |
| Select Sector Spdr Tr (XLV) | that day | -0.91% | still updating |
| Select Sector Spdr Tr (XLV) | three days earlier | -2.16% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | +0.42% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 68 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 35 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 42 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 47 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 68 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 82 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 48 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 84 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “Insider Buying Signals: 3 Healthcare Stocks to Watch”
Companies tied to this story
- XLV Select Sector Spdr Tr
In “Insider Buying Signals: 3 Healthcare Stocks to Watch,” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story
- XBI Spdr Series Trust
Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence in the 11 Nov 2026 story “Insider Buying Signals: 3 Healthcare Stocks to Watch.” Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story
- LLY Eli Lilly
Eli Lilly (LLY) is linked, with no stored direction, medium confidence in the 11 Nov 2026 story “Insider Buying Signals: 3 Healthcare Stocks to Watch.” Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story
- JNJ Johnson & Johnson
Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence in the 11 Nov 2026 story “Insider Buying Signals: 3 Healthcare Stocks to Watch.” Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story
- PFE Pfizer
In “Insider Buying Signals: 3 Healthcare Stocks to Watch,” Pfizer (PFE) is linked, with no stored direction, medium confidence. Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story
- MRK Merck
For “Insider Buying Signals: 3 Healthcare Stocks to Watch,” Merck (MRK) is linked, with no stored direction, medium confidence. Reason on file: Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story
How “Insider Buying Signals: 3 Healthcare Stocks to Watch” reaches Select Sector Spdr Tr (XLV)
On 11 Nov 2026, “Insider Buying Signals: 3 Healthcare Stocks to Watch” is the story that connects Select Sector Spdr Tr (XLV) to this story.
The link for Select Sector Spdr Tr (XLV) is this: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story
Spdr Series Trust (XBI) is here too. Its reason reads: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story
The price range for Select Sector Spdr Tr (XLV), and the dates in the story
LLY traded between 1176.87 and 1452.66 across 20 sessions. The latest close on file is 1433.04.
How strong the case is around Select Sector Spdr Tr (XLV)
46 out of 100Price not final
“Insider Buying Signals: 3 Healthcare Stocks to Watch” scores 46 out of 100. The score uses 1 sources, and 6 linked companies. The price is not final yet.